Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline versus prednisone effects on the microbiome in chronic rhinosinusitis
ACTRN12615000169549Phase 4Recruiting
- Sponsor
- Associate Professor Richard Douglas
- Start
- Feb 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic rhinosinusitis (CRS) comparing Doxycycline with Prednisone (2 arms). Primary endpoint: Mucous microbiology. Started Feb 2015; status: recruiting.
02
Drugs
doxycyclineprednisone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12615000169549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000169549.